Drug
Sodium Zirconium Cyclosilicate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Blood Potassium Increased | 191 | 67.6 | 71.2 | signal |
| 2 | Hyperkalaemia | 150 | 24.5 | 25.5 | signal |
| 3 | End Stage Renal Disease | 55 | 17.0 | 17.2 | signal |
| 4 | Glomerular Filtration Rate Decreased | 23 | 10.8 | 10.9 | signal |
| 5 | Hypokalaemia | 71 | 8.8 | 8.9 | signal |
| 6 | Blood Potassium Decreased | 44 | 8.3 | 8.4 | signal |
| 7 | Death | 1,088 | 7.2 | 9.8 | signal |
| 8 | Oedema | 68 | 7.1 | 7.3 | signal |
| 9 | Ileus | 15 | 6.9 | 6.9 | signal |
| 10 | Cardiac Failure | 90 | 6.4 | 6.5 | signal |
| 11 | Dialysis | 14 | 5.6 | 5.6 | signal |
| 12 | Nephropathy | 9 | 5.4 | 5.5 | signal |
| 13 | Chronic Kidney Disease | 72 | 5.3 | 5.4 | signal |
| 14 | Toxic Epidermal Necrolysis | 14 | 5.3 | 5.3 | signal |
| 15 | Renal Disorder | 43 | 5.2 | 5.3 | signal |
| 16 | Inability To Afford Medication | 9 | 5.2 | 5.2 | signal |
| 17 | Renal Impairment | 69 | 4.7 | 4.8 | signal |
| 18 | Blood Calcium Decreased | 9 | 4.5 | 4.5 | signal |
| 19 | Incorrect Route Of Product Administration | 13 | 4.4 | 4.4 | signal |
| 20 | Blood Creatinine Increased | 47 | 4.1 | 4.1 | signal |
| 21 | Stevens-johnson Syndrome | 16 | 4.1 | 4.1 | signal |
| 22 | Blood Urea Increased | 12 | 4.0 | 4.1 | signal |
| 23 | Intestinal Perforation | 8 | 4.0 | 4.0 | signal |
| 24 | Proteinuria | 12 | 3.6 | 3.6 | signal |
| 25 | Choking | 12 | 3.5 | 3.5 | signal |
| 26 | Product Taste Abnormal | 8 | 3.4 | 3.4 | signal |
| 27 | Renal Failure | 79 | 3.4 | 3.4 | signal |
| 28 | Blindness | 23 | 3.2 | 3.2 | signal |
| 29 | Cardiac Failure Congestive | 45 | 3.2 | 3.2 | signal |
| 30 | Erythema Multiforme | 5 | 3.0 | 3.0 | signal |
| 31 | Colon Cancer | 8 | 3.0 | 3.0 | signal |
| 32 | Therapy Change | 5 | 2.9 | 2.9 | signal |
| 33 | Multiple Organ Dysfunction Syndrome | 14 | 2.8 | 2.9 | signal |
| 34 | Mouth Ulceration | 10 | 2.7 | 2.7 | signal |
| 35 | Fluid Overload | 7 | 2.7 | 2.7 | signal |
| 36 | Metabolic Acidosis | 15 | 2.7 | 2.7 | signal |
| 37 | Dementia | 13 | 2.6 | 2.7 | signal |
| 38 | Pharyngitis Streptococcal | 5 | 2.6 | 2.6 | no signal |
| 39 | Hypertensive Crisis | 5 | 2.5 | 2.5 | no signal |
| 40 | Rash Papular | 10 | 2.5 | 2.5 | signal |
| 41 | Posterior Reversible Encephalopathy Syndrome | 4 | 2.4 | 2.4 | no signal |
| 42 | Cerebral Infarction | 10 | 2.3 | 2.3 | signal |
| 43 | Sickle Cell Anaemia With Crisis | 6 | 2.2 | 2.2 | no signal |
| 44 | Fracture | 7 | 2.1 | 2.1 | no signal |
| 45 | Cerebral Haemorrhage | 13 | 2.1 | 2.1 | signal |
| 46 | Blindness Unilateral | 5 | 2.0 | 2.0 | no signal |
| 47 | Myelodysplastic Syndrome | 5 | 2.0 | 2.0 | no signal |
| 48 | Therapy Interrupted | 22 | 1.8 | 1.8 | no signal |
| 49 | Diabetes Mellitus Inadequate Control | 5 | 1.6 | 1.6 | no signal |
| 50 | Neoplasm Malignant | 17 | 1.4 | 1.4 | no signal |
| 51 | Myelosuppression | 4 | 0.7 | 0.7 | no signal |
| 52 | Renal Cancer | 5 | 0.6 | 0.6 | no signal |